Group items matching

in title, tags, annotations or url

PPE 2023: The Physician Assistant Hospitalist CAQ Review is organized by Provider Practice Essentials, LLC. A unique program for both Nurse Practitioners and Physician Assistants . Additional modules include Screening Guidelines, Medicolegal, Cultural Competency, Professionalism, and more!

Former superintendent pharmacist and National Pharmacy Association (NPA) director, Phil Galt, has been appointed the new UK managing director for pharmacy software supplier Cegedim Rx. The position was previously held by Adam Dennett, who resigned after a successful ten-year tenure to pursue a new career outside healthcare, the company said. Cegedim Rx, the pharmacy entity of Cegedim healthcare Solutions UK, announced the new appointment this month (April 5). Tristan de Foucher, head of European operations for Cegedim Group, said: "Adam has been a force of nature in this business for the past 10 years. Under his leadership, the team has continuously and successfully invested in and driven product innovation to stay ahead of the ever-changing demands placed upon community pharmacy." Galt has over 20 years of experience as a qualified pharmacist and a successful business leader. He has worked extensively in community pharmacy, focusing on both care delivery and technology implementation.

Taking care of its members' hearts is something Medicare takes to heart. Medicare covers a variety of screenings. They help identify risk factors early. This way members can take quick action based on their results.

Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands Company, a company owned by American private equity firm Yellow Wood Partners. The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer, valued at around $80 million. Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt. ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024. Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being rigorous and disciplined where there are opportunities for divestment. "While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.

Trainee pharmacists across Great Britain are preparing to participate in Pharmacist Support's annual Trainee ACTNow Wellbeing Campaign, scheduled from May 20th to 24th. Organised by the charity, this initiative aims to provide essential support as trainees approach the culmination of their placements and gear up for the General Pharmaceutical Council (GPhC) assessment. Danielle Hunt, Chief Executive of Pharmacist Support, highlighted the campaign's focus on addressing the significant stress and pressure trainees may experience during this critical period. She stated: "We understand the anxiety and pressure they may feel, not only in preparing for the assessment but also in stepping into their roles as registered pharmacists."

Discover the healing power of Ayurveda with Bhrigu Herbals. Shop herbal remedies, supplements, and wellness products for a balanced life.

Shop our wide range of Ayurvedic products online. Discover natural remedies and health solutions for your wellness needs by Bhrigu Herbals